Theravance Biopharma (0TB.F) Q1 2025 Earnings

26FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.31
-0.27
-0.23
-0.19

Details

Expected EPS
-0.18977216500000002
Actual EPS
-0.29547650000000003
Surprise EPS
-0.11
Surprise Percent
+55.7%

Description

Theravance Biopharma (0TB.F) has reported earnings of -0.29547650000000003 per share for Q1 2025.

0 Comments

Share your thoughts